Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06399692 · ClinicalTrials.gov registry record · Phase 3
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women
A Phase 3 study of Coronary Artery Disease, sponsored by Weill Medical College of Cornell University.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 600
- Enrollment target
- 18
- Study locations
NCT06399692 is a Phase 3 study of Coronary Artery Disease that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 600 participants, below the 1,284-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (53% lower). The trial reports 18 study locations across 11 states.
The verdict
NCT06399692, a Phase 3 study of Coronary Artery Disease, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 600 participants
- Enrollment target
- 18
- Study locations
Study Summary
This is a research study in women to compare the outcomes of two procedures that restore blood flow to the arteries of the heart. In one procedure the blockages are ballooned and then stented with a small wire mesh tube through a small incision in the wrist or the groin. The other procedure is an open-heart operation in which healthy blood vessels from inside the chest, leg, and/or forearm are used to "bypass" the blockages (like a detour). Outcomes will be measured by comparing survival and improvement in quality-of-life.
Conditions Studied
Interventions
- PROCEDURE Coronary artery bypass grafting (CABG)
- PROCEDURE Percutaneous coronary intervention (PCI)
Study Locations (18)
New York
- NewYork-Presbyterian Hospital - Queens - Flushing
- Icahn School of Medicine - Mount Sinai Morningside - New York
- Icahn School of Medicine - Mount Sinai Hospital - New York
- Columbia University Irving Medical Center/NewYork-Presbyterian Hospital - New York
- Weill Cornell Medicine / NYPH - New York
- Westchester Medical Center - Valhalla
Kentucky
- Baptist Health Lexington - Lexington
- Baptist Health Louisville - Louisville
Tennessee
- Methodist Le Bonheur Healthcare - Memphis
- Ascension Saint Thomas Hospital - Nashville
California
- Adventist Health Glendale - Glendale
Georgia
- Emory University - Atlanta
Indiana
- Ascension St. Vincent Cardiovascular Research Institute - Carmel
Massachusetts
- Massachusetts General Hospital - Boston
New Jersey
- Englewood Hospital - Englewood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2024-09-16 |
| Est. Completion | 2039-01-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06399692
The ClinicalTrials.gov registry entry for NCT06399692 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,284-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (53% lower). The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 2 interventions - of which Coronary artery bypass grafting (CABG) is the first listed.
NCT06399692 reports 18 study locations spanning 11 distinct geographic areas - top geographies include New York, Kentucky, Tennessee.
Frequently Asked Questions
What is clinical trial NCT06399692 about?
NCT06399692 is a clinical study titled "REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women". This is a research study in women to compare the outcomes of two procedures that restore blood flow to the arteries of the heart. In one procedure the blockages are ballooned and then stented with a small wire mesh tube through a small incision in the wrist or the groin. The other procedure is an op...
What is the current status of trial NCT06399692?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 600 participants. The study started on 2024-09-16. Estimated completion is 2039-01-01.
What conditions does trial NCT06399692 study?
This clinical trial studies the following conditions: Coronary Artery Disease.
What interventions are being tested in trial NCT06399692?
The interventions under investigation include: Coronary artery bypass grafting (CABG) (PROCEDURE), Percutaneous coronary intervention (PCI) (PROCEDURE).
Who is sponsoring clinical trial NCT06399692?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06399692 being conducted?
This trial has 18 study locations across California, Georgia, Indiana, Kentucky, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A CCTA Imaging Trial to Evaluate the Effect of Obicetrapib/Ezetimibe on Coronary Plaque
RECRUITING · Phase 3
-
RAdiolabeled Perfusion to Identify Coronary Artery Disease Using WAter To Evaluate Responses of Myocardial FLOW (RAPID-WATER-FLOW)
RECRUITING · Phase 3
-
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities
RECRUITING · Phase 3
-
PANDORA: Delirium Prevention After Cardiac Surgery Using IV Acetaminophen to Prevent Postoperative Delirium in Older Cardiac Surgical Patients
ACTIVE NOT RECRUITING · Phase 3
-
Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events
ACTIVE NOT RECRUITING · Phase 3
-
Cardiovascular Outcomes Of Diet Counseling
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.